Literature DB >> 8082896

Nucleotide sequence of a novel HLA-B44 subtype B*4405.

Z Yao1, A Volgger, S Scholz, J Bönisch, E D Albert.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8082896     DOI： 10.1007/bf00189980

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  4 in total

1.  Polymerase-chain-reaction-based analysis of polymorphism in the HLA-B gene.

Authors:  M Yoshida; A Kimura; F Numano; T Sasazuki
Journal:  Hum Immunol       Date:  1992-08       Impact factor: 2.850

2.  Nomenclature for factors of the HLA system, 1991. WHO Nomenclature Committee for factors of the HLA system.

Authors:  J G Bodmer; S G Marsh; E D Albert; W F Bodmer; B Dupont; H A Erlich; B Mach; W R Mayr; P Parham; T Sasazuki
Journal:  Tissue Antigens       Date:  1992-04

3.  Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44.

Authors:  K Fleischhauer; N A Kernan; R J O'Reilly; B Dupont; S Y Yang
Journal:  N Engl J Med       Date:  1990-12-27       Impact factor: 91.245

4.  Identification of two major HLA-B44 subtypes and a novel B44 sequence (B*4404). Oligotyping and solid phase sequencing of polymerase chain reaction products.

Authors:  Z Yao; E Keller; S Scholz; A McNicholas; A Volgger; E D Albert
Journal:  Hum Immunol       Date:  1995-01       Impact factor: 2.850
  4 in total
  4 in total

1.  Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccines.

Authors:  R Khanna; S R Burrows; A Neisig; J Neefjes; D J Moss; S L Silins
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  A new HLA-B44 subtype, B*4406, differing in exon 2.

Authors:  Z Yao; A Lattermann; A Volgger; A McNicholas; G Mueller-Eckhardt; E D Albert
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

3.  Sequence polymorphism in the HLA-B promoter region.

Authors:  Z Yao; A Volgger; S Scholz; E D Albert
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

4.  A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3.

Authors:  J Herman; P van der Bruggen; I F Luescher; S Mandruzzato; P Romero; J Thonnard; K Fleischhauer; T Boon; P G Coulie
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.